TBQ-18467-48696
3 vaccinations
1 coded response
1 check-in
1 free-text entry
0 call cases
- Sex
- —
- Age at first dose
- 36-40
- ZIP prefix
- 804 / CO
- Registered
- 2021-11-07
- Relationship
- Self
- Race
- N/A
- Ethnicity
- N/A
Timeline
-
2021-03-18
Dose 1 — Pfizer-BioNTech
-
2021-04-08
Dose 2 — Pfizer-BioNTech
-
2021-11-03
Dose 3 — Pfizer-BioNTech
-
2021-11-07
Registered in v-safe
-
2021-11-07
Survey response — days 1–6 daily, dose 3MedDRA: Pregnancy — Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: PregnantMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-18 | Pfizer-BioNTech | No |
| 2 | 2021-04-08 | Pfizer-BioNTech | No |
| 3 | 2021-11-03 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Pregnant
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release